Efficacy of Cetylpyridinium Chloride mouthwash against SARS‐CoV‐2: A systematic review of randomized controlled trials
Molecular Oral Microbiology · 2023-06 · 38 (3) · 171-180
DOI: 10.1111/omi.12408 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Molecular Oral Microbiology, online erschienen am 03.03.2023. Verfasst von Filippo D'Amico und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Dental Plaque, COVID-19. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
COVID‐19 is a transmissible respiratory and multisystem disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Viral transmission occurs mainly through the spread of salivary droplets or aerosol from an infected subject. Studies suggest that salivary viral load is correlated with disease severity and probability of transmission. Cetylpyridinium chloride mouthwash has been found to be effective in reducing salivary viral load. The aim of this systematic review of randomized controlled trials is to evaluate the efficacy of the mouthwash ingredient cetylpyridinium chloride on salivary viral load in SARS‐CoV‐2 infection.
Methods
Randomized controlled trials comparing cetylpyridinium chloride mouthwash with placebo and other mouthwash ingredients in SARS‐CoV‐2 positive individuals were identified and evaluated.
Results
Six studies with a total of 301 patients that met the inclusion criteria were included. The studies reported the efficacy of cetylpyridinium chloride mouthwashes in reduction on SARS‐CoV‐2 salivary viral load compared to placebo and other mouthwash ingredients.
Conclusion
Mouthwashes containing cetylpyridinium chloride are effective against salivary viral load of SARS‐CoV‐2 in vivo. There is also the possibility that the use of mouthwash containing cetylpyridinium chloride in SARS‐CoV‐2 positive subjects could reduce transmissibility and severity of COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Infection Control Committee, IRCCS San Raffaele Hospital, Milan, Italy.
- Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Department of Radiology, Salisbury District Hospital, Salisbury, UK.
- Vita-Salute San Raffaele University, Milan, Italy.
Zitieren
APA
D'Amico, F., Moro, M., Saracino, M., Marmiere, M., Cilona, M. B., Lloyd-Jones, G., & Zangrillo, A. (2023). Efficacy of Cetylpyridinium Chloride mouthwash against SARS‐CoV‐2: A systematic review of randomized controlled trials. Molecular Oral Microbiology, 38(3), 171-180. https://doi.org/10.1111/omi.12408
Vancouver
D'Amico F, Moro M, Saracino M, Marmiere M, Cilona MB, Lloyd-Jones G, et al. Efficacy of Cetylpyridinium Chloride mouthwash against SARS‐CoV‐2: A systematic review of randomized controlled trials. Molecular Oral Microbiology. 2023;38(3):171-180. doi:10.1111/omi.12408
BibTeX
@article{DAmico2023,
author = {D'Amico, Filippo and Moro, Matteo and Saracino, Marco and Marmiere, Marilena and Cilona, Maria Bernadette and Lloyd-Jones, Graham and Zangrillo, Alberto},
title = {Efficacy of Cetylpyridinium Chloride mouthwash against SARS‐CoV‐2: A systematic review of randomized controlled trials},
journal = {Molecular Oral Microbiology},
year = {2023},
volume = {38},
number = {3},
pages = {171--180},
doi = {10.1111/omi.12408}
}
EUVIMED